非肿瘤性冠状动脉栓塞所致急性心肌梗死的临床特征与预后
该研究回顾性纳入2006例急性心肌梗死患者,其中非肿瘤性冠状动脉栓塞46例(2.3%),心房颤动为最常见病因(32例,69.6%)。与无栓塞对照组相比,非肿瘤性栓塞组心房颤动发生率更高、左房及左室径更大、左室射血分数更低、ST段抬高型心肌梗死发生率更低、多支冠状动脉狭窄比例更低、介入治疗比例更低,而单纯抗血栓药物治疗及手动血栓抽吸比例更高,再灌注后TIMI血流分级更低、校正TIMI帧数更高。中位随访864天,两组总生存率无统计学差异。
要点
- 非肿瘤性冠状动脉栓塞占急性心肌梗死2.3%,心房颤动是最常见病因(32/46,69.6%)。
- 非肿瘤性栓塞组心房颤动发生率更高,左房径、左室舒张末径及收缩末径更大,左室射血分数更低(均p<0.05)。
- 非肿瘤性栓塞组ST段抬高型心肌梗死发生率更低、多支冠状动脉狭窄比例更低、介入治疗比例更低,而单纯抗血栓药物治疗及手动血栓抽吸比例更高(均p<0.05)。
- 再灌注后非肿瘤性栓塞组TIMI血流分级更低、校正TIMI帧数更高(均p<0.05)。
- 中位随访864天(四分位距413–1272天),非肿瘤性栓塞组与无栓塞组总生存率无统计学差异。
适用人群与场景
- 2006例于2014年1月至2018年10月在本医疗中心连续纳入的急性心肌梗死患者。
- 非肿瘤性冠状动脉栓塞组46例,无栓塞对照组为其余患者。
诊断标准与关键阈值
- 非肿瘤性冠状动脉栓塞依据血管造影、生化和影像学标准诊断。
研究设计与关键结果
- 研究类型为回顾性研究,样本量2006例,人群为急性心肌梗死患者,分组为非肿瘤性冠状动脉栓塞组(n=46)与无栓塞对照组。
- 非肿瘤性栓塞组心房颤动32例(69.6%),为最常见病因。
- 与对照组相比,非肿瘤性栓塞组心房颤动发生率更高、左房径更大、左室舒张末径更大、左室收缩末径更大、左室射血分数更低、ST段抬高型心肌梗死发生率更低、低密度脂蛋白胆固醇水平更低(均p<0.05)。
- 与对照组相比,非肿瘤性栓塞组多支冠状动脉狭窄发生率更低、罪犯病变狭窄程度更低、血管成形术比例更低,而手动血栓抽吸比例及单纯抗血栓药物治疗比例更高(均p<0.05)。
- 与对照组相比,非肿瘤性栓塞组再灌注后TIMI血流分级更低、校正TIMI帧数更高(均p<0.05)。
- 中位随访864天(四分位距413–1272天),两组总生存率无统计学差异。
证据类型、等级与局限
- 证据类型:回顾性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文结论指出非肿瘤性冠状动脉栓塞总体发生率为2.3%,心房颤动为其最常见病因,非肿瘤性栓塞所致急性心肌梗死患者与无栓塞患者的中期总生存率相似。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Several studies have indicated that acute myocardial infarction (AMI) secondary to coronary artery embolism (CE) has a poor prognosis. However, in the latter studies, CE of tumor origin accounts for a considerable proportion of cases and the clinical features and contribution to overall prognosis of non-tumor CE are unknown and therefore the subject of this study.
METHODS: We retrospectively studied 2006 consecutive patients with AMI at our medical center from January 2014 to October 2018. Non-tumor CE was diagnosed based on angiographic, biochemical, and imaging criteria. Patients were divided into two groups: patients without CE (control) and patients with non-tumor CE.
RESULTS: Atrial fibrillation was the most frequent etiology (n = 32, 69.6%) in the non-tumor CE group (n = 46). Compared with the control group, the non-tumor CE group had (all p < 0.05): higher incidence of atrial fibrillation; larger left atrial diameter, left ventricular end-diastolic diameter and left ventricular end-systolic diameter; lower left ventricular ejection fraction, ST-segment-elevation myocardial infarction incidence and low density lipoprotein cholesterol level; lower incidence of multivessel coronary stenosis, level of culprit lesion stenosis and proportion of angioplasty; higher ratio of manual thrombectomy and antithrombotic drugs alone therapy; lower thrombolysis in myocardial infarction (TIMI) grade and higher corrected TIMI frame counts (CTFC) after reperfusion; and statistically similar overall survival at median 864 (interquartile range, 413-1272) days.
CONCLUSIONS: The overall incidence of non-tumor CE was 2.3%, with atrial fibrillation as its most common etiology. Midterm overall survival was similar between AMI patients secondary to non-tumor CE and those without CE.
参考来源
- Xiang G, Shan P, Zhou C, et al. Clinical features and prognosis of acute myocardial infarction caused by non-tumor origin coronary artery embolism. Am J Emerg Med. 2020. PMID: 32229223. doi:10.1016/j.ajem.2020.03.043
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。